Sage Therapeutics, Inc.

Ownership Transactions Reported by 19 Insiders

Symbol
SAGE on Nasdaq
Industry
Pharmaceutical Preparations
Location
55 Cambridge Parkway, Cambridge, MA

There are no Buy or Sell transactions made by insiders since 12/5/2024

Sage Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Jeffrey M. Jonas Director $2.47M Jun 10, 2024
Iguchi Kimi CFO & Treasurer $729K Aug 5, 2024
Stephen Kanes Chief Medical Officer $260K Oct 19, 2021
Laura Gault Chief Medical Officer $249K Feb 13, 2025
Anne Marie Cook SVP, GC & Secretary $215K Aug 5, 2024
Elizabeth Barrett Director $57.8K Jun 10, 2024
Christopher Benecchi Chief Operating Officer $0 Jul 31, 2025
Gregory L. Shiferman Senior Vice President, General Counsel and Secretary $0 Jul 31, 2025
Michael C. Quirk Chief Scientific Officer and Interim Head of R&D $0 Jul 31, 2025
Barry E. Greene President and CEO, Director $0 Jul 31, 2025
James M. Frates Director $0 Jul 31, 2025
Elizabeth Barrett Director $0 Jul 31, 2025
George Golumbeski Director $0 Jul 31, 2025
Geno J. Germano Director Jul 31, 2025
Kevin P. Starr Director Jun 15, 2023
Albert Robichaud Chief Scientific Officer Feb 13, 2023
Steven M. Paul Director Jan 3, 2024
Jessica Federer Director Jul 31, 2025
Michael F. Cola Director Jul 31, 2025

Recent Insider Transactions by Companies or Individuals for Sage Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.